Cellectis CLLS
NASDAQ CLLS
$1.06 +0.07 (+7.07%)
As of: Oct 21, 2026 · 10:05 AM EDT

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2025)

Updated

Cellectis (CLLS) posted Share-based Compensation (IS) of -$987,000 for FY2022, compared with -$3.6 million in FY2021.

Analysis

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2025) Analysis & Trends

Since FY2015, Cellectis has reported Share-based Compensation (IS) for 8 years.

  • The FY2022 figure stands as the highest annual Share-based Compensation (IS) in data going back to FY2015.
  • Business Quant data shows CLLS's Share-based Compensation (IS) at -$3.6 million in FY2021, -$2.51 million in FY2020, -$7.83 million in FY2019 and -$8.07 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn -
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn -
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn -
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn -
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn -
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn -
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn -
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn -
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn -
10 Cellectis 106.30 Mn -647.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,602.00
Sep 30, 2024 -566.00
Sep 30, 2015 10.53 Mn
Mar 31, 2015 947,929.46
API Access

Cellectis Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CLLS&period=max&api_key=YOUR_API_KEY